Medical Care

Global CAR T-Cell Immunotherapy Market Insights, Forecast to 2030

CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
Market Analysis and Insights: Global CAR T-Cell Immunotherapy Market
The global CAR T-Cell Immunotherapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of CAR T-Cell Immunotherapy include AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, Gilead, Pfizer, Cellectis and Bellicum, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
CAR T-Cell Immunotherapy is widely used in various fields, such as Hematologic Malignancies and Solid Malignancies, etc. Hematologic Malignancies provides greatest supports to the CAR T-Cell Immunotherapy industry development. In 2023, global % revenue of CAR T-Cell Immunotherapy went into Hematologic Malignancies filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for CAR T-Cell Immunotherapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of CAR T-Cell Immunotherapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CAR T-Cell Immunotherapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CAR T-Cell Immunotherapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CAR T-Cell Immunotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CAR T-Cell Immunotherapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Hematologic Malignancies
Solid Malignancies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CAR T-Cell Immunotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR T-Cell Immunotherapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR T-Cell Immunotherapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hematologic Malignancies
1.3.3 Solid Malignancies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Immunotherapy Market Perspective (2019-2030)
2.2 Global CAR T-Cell Immunotherapy Growth Trends by Region
2.2.1 CAR T-Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CAR T-Cell Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 CAR T-Cell Immunotherapy Market Dynamics
2.3.1 CAR T-Cell Immunotherapy Industry Trends
2.3.2 CAR T-Cell Immunotherapy Market Drivers
2.3.3 CAR T-Cell Immunotherapy Market Challenges
2.3.4 CAR T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CAR T-Cell Immunotherapy by Players
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Players (2019-2024)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CAR T-Cell Immunotherapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2023
3.5 Global Key Players of CAR T-Cell Immunotherapy Head office and Area Served
3.6 Global Key Players of CAR T-Cell Immunotherapy, Product and Application
3.7 Global Key Players of CAR T-Cell Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030)
5 CAR T-Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CAR T-Cell Immunotherapy Market Size (2019-2030)
6.2 North America CAR T-Cell Immunotherapy Market Size by Type
6.2.1 North America CAR T-Cell Immunotherapy Market Size by Type (2019-2024)
6.2.2 North America CAR T-Cell Immunotherapy Market Size by Type (2025-2030)
6.2.3 North America CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
6.3 North America CAR T-Cell Immunotherapy Market Size by Application
6.3.1 North America CAR T-Cell Immunotherapy Market Size by Application (2019-2024)
6.3.2 North America CAR T-Cell Immunotherapy Market Size by Application (2025-2030)
6.3.3 North America CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
6.4 North America CAR T-Cell Immunotherapy Market Size by Country
6.4.1 North America CAR T-Cell Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
6.4.3 North America CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe CAR T-Cell Immunotherapy Market Size (2019-2030)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Type
7.2.1 Europe CAR T-Cell Immunotherapy Market Size by Type (2019-2024)
7.2.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2025-2030)
7.2.3 Europe CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Application
7.3.1 Europe CAR T-Cell Immunotherapy Market Size by Application (2019-2024)
7.3.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2025-2030)
7.3.3 Europe CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
7.4 Europe CAR T-Cell Immunotherapy Market Size by Country
7.4.1 Europe CAR T-Cell Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
7.4.3 Europe CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CAR T-Cell Immunotherapy Market Size (2019-2030)
8.2 China CAR T-Cell Immunotherapy Market Size by Type
8.2.1 China CAR T-Cell Immunotherapy Market Size by Type (2019-2024)
8.2.2 China CAR T-Cell Immunotherapy Market Size by Type (2025-2030)
8.2.3 China CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
8.3 China CAR T-Cell Immunotherapy Market Size by Application
8.3.1 China CAR T-Cell Immunotherapy Market Size by Application (2019-2024)
8.3.2 China CAR T-Cell Immunotherapy Market Size by Application (2025-2030)
8.3.3 China CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia CAR T-Cell Immunotherapy Market Size (2019-2030)
9.2 Asia CAR T-Cell Immunotherapy Market Size by Type
9.2.1 Asia CAR T-Cell Immunotherapy Market Size by Type (2019-2024)
9.2.2 Asia CAR T-Cell Immunotherapy Market Size by Type (2025-2030)
9.2.3 Asia CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
9.3 Asia CAR T-Cell Immunotherapy Market Size by Application
9.3.1 Asia CAR T-Cell Immunotherapy Market Size by Application (2019-2024)
9.3.2 Asia CAR T-Cell Immunotherapy Market Size by Application (2025-2030)
9.3.3 Asia CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
9.4 Asia CAR T-Cell Immunotherapy Market Size by Region
9.4.1 Asia CAR T-Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia CAR T-Cell Immunotherapy Market Size by Region (2019-2024)
9.4.3 Asia CAR T-Cell Immunotherapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.1.5 AbbVie Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene CAR T-Cell Immunotherapy Introduction
11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.2.5 Celgene Recent Developments
11.3 Kite Pharma
11.3.1 Kite Pharma Company Details
11.3.2 Kite Pharma Business Overview
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.3.5 Kite Pharma Recent Developments
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Details
11.4.2 Oxford BioMedica Business Overview
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.4.5 Oxford BioMedica Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis CAR T-Cell Immunotherapy Introduction
11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.5.5 Novartis Recent Developments
11.6 Gilead
11.6.1 Gilead Company Details
11.6.2 Gilead Business Overview
11.6.3 Gilead CAR T-Cell Immunotherapy Introduction
11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.6.5 Gilead Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.7.5 Pfizer Recent Developments
11.8 Cellectis
11.8.1 Cellectis Company Details
11.8.2 Cellectis Business Overview
11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.8.5 Cellectis Recent Developments
11.9 Bellicum
11.9.1 Bellicum Company Details
11.9.2 Bellicum Business Overview
11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.9.5 Bellicum Recent Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Details
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.10.5 Mustang Bio Recent Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Details
11.11.2 CARsgen Therapeutics Business Overview
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.11.5 CARsgen Therapeutics Recent Developments
11.12 Xyphos
11.12.1 Xyphos Company Details
11.12.2 Xyphos Business Overview
11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.12.5 Xyphos Recent Developments
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Details
11.13.2 Minerva Biotechnologies Business Overview
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.13.5 Minerva Biotechnologies Recent Developments
11.14 Adaptimmune
11.14.1 Adaptimmune Company Details
11.14.2 Adaptimmune Business Overview
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.14.5 Adaptimmune Recent Developments
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Details
11.15.2 Ziopharm Oncology Business Overview
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.15.5 Ziopharm Oncology Recent Developments
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Details
11.16.2 Aurora Biopharma Business Overview
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.16.5 Aurora Biopharma Recent Developments
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Details
11.17.2 Creative Biolabs Business Overview
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2019-2024)
11.17.5 Creative Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global CAR T-Cell Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CAR T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global CAR T-Cell Immunotherapy Market Share by Region (2019-2024)
Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global CAR T-Cell Immunotherapy Market Share by Region (2025-2030)
Table 10. CAR T-Cell Immunotherapy Market Trends
Table 11. CAR T-Cell Immunotherapy Market Drivers
Table 12. CAR T-Cell Immunotherapy Market Challenges
Table 13. CAR T-Cell Immunotherapy Market Restraints
Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Revenue Share by Players (2019-2024)
Table 16. Global Top CAR T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2023)
Table 17. Global CAR T-Cell Immunotherapy Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of CAR T-Cell Immunotherapy, Headquarters and Area Served
Table 20. Global Key Players of CAR T-Cell Immunotherapy, Product and Application
Table 21. Global Key Players of CAR T-Cell Immunotherapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2019-2024)
Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2025-2030)
Table 27. Global CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global CAR T-Cell Immunotherapy Revenue Share by Application (2019-2024)
Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global CAR T-Cell Immunotherapy Revenue Share by Application (2025-2030)
Table 31. North America CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America CAR T-Cell Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America CAR T-Cell Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America CAR T-Cell Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe CAR T-Cell Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe CAR T-Cell Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe CAR T-Cell Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. China CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 46. China CAR T-Cell Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
Table 47. China CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 48. China CAR T-Cell Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia CAR T-Cell Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia CAR T-Cell Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia CAR T-Cell Immunotherapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia CAR T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia CAR T-Cell Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie CAR T-Cell Immunotherapy Product
Table 66. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 67. AbbVie Recent Developments
Table 68. Celgene Company Details
Table 69. Celgene Business Overview
Table 70. Celgene CAR T-Cell Immunotherapy Product
Table 71. Celgene Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 72. Celgene Recent Developments
Table 73. Kite Pharma Company Details
Table 74. Kite Pharma Business Overview
Table 75. Kite Pharma CAR T-Cell Immunotherapy Product
Table 76. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 77. Kite Pharma Recent Developments
Table 78. Oxford BioMedica Company Details
Table 79. Oxford BioMedica Business Overview
Table 80. Oxford BioMedica CAR T-Cell Immunotherapy Product
Table 81. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 82. Oxford BioMedica Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis CAR T-Cell Immunotherapy Product
Table 86. Novartis Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Gilead Company Details
Table 89. Gilead Business Overview
Table 90. Gilead CAR T-Cell Immunotherapy Product
Table 91. Gilead Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 92. Gilead Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer CAR T-Cell Immunotherapy Product
Table 96. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Cellectis Company Details
Table 99. Cellectis Business Overview
Table 100. Cellectis CAR T-Cell Immunotherapy Product
Table 101. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 102. Cellectis Recent Developments
Table 103. Bellicum Company Details
Table 104. Bellicum Business Overview
Table 105. Bellicum CAR T-Cell Immunotherapy Product
Table 106. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 107. Bellicum Recent Developments
Table 108. Mustang Bio Company Details
Table 109. Mustang Bio Business Overview
Table 110. Mustang Bio CAR T-Cell Immunotherapy Product
Table 111. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 112. Mustang Bio Recent Developments
Table 113. CARsgen Therapeutics Company Details
Table 114. CARsgen Therapeutics Business Overview
Table 115. CARsgen Therapeutics CAR T-Cell Immunotherapy Product
Table 116. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 117. CARsgen Therapeutics Recent Developments
Table 118. Xyphos Company Details
Table 119. Xyphos Business Overview
Table 120. Xyphos CAR T-Cell Immunotherapy Product
Table 121. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 122. Xyphos Recent Developments
Table 123. Minerva Biotechnologies Company Details
Table 124. Minerva Biotechnologies Business Overview
Table 125. Minerva Biotechnologies CAR T-Cell Immunotherapy Product
Table 126. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 127. Minerva Biotechnologies Recent Developments
Table 128. Adaptimmune Company Details
Table 129. Adaptimmune Business Overview
Table 130. Adaptimmune CAR T-Cell Immunotherapy Product
Table 131. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 132. Adaptimmune Recent Developments
Table 133. Ziopharm Oncology Company Details
Table 134. Ziopharm Oncology Business Overview
Table 135. Ziopharm Oncology CAR T-Cell Immunotherapy Product
Table 136. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 137. Ziopharm Oncology Recent Developments
Table 138. Aurora Biopharma Company Details
Table 139. Aurora Biopharma Business Overview
Table 140. Aurora Biopharma CAR T-Cell Immunotherapy Product
Table 141. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 142. Aurora Biopharma Recent Developments
Table 143. Creative Biolabs Company Details
Table 144. Creative Biolabs Business Overview
Table 145. Creative Biolabs CAR T-Cell Immunotherapy Product
Table 146. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 147. Creative Biolabs Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global CAR T-Cell Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global CAR T-Cell Immunotherapy Market Share by Application: 2023 VS 2030
Figure 7. Hematologic Malignancies Case Studies
Figure 8. Solid Malignancies Case Studies
Figure 9. CAR T-Cell Immunotherapy Report Years Considered
Figure 10. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global CAR T-Cell Immunotherapy Market Share by Region: 2023 VS 2030
Figure 13. Global CAR T-Cell Immunotherapy Market Share by Players in 2023
Figure 14. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2023
Figure 16. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
Figure 18. North America CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
Figure 19. North America CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 20. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe CAR T-Cell Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
Figure 23. Europe CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
Figure 24. Europe CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
Figure 25. Europe CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 26. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. China CAR T-Cell Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
Figure 33. China CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
Figure 34. China CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
Figure 35. Asia CAR T-Cell Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
Figure 36. Asia CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
Figure 37. Asia CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
Figure 38. Asia CAR T-Cell Immunotherapy Market Share by Region (2019-2030)
Figure 39. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. China Taiwan CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Share by Type (2019-2030)
Figure 47. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Share by Application (2019-2030)
Figure 48. Middle East, Africa, and Latin America CAR T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 49. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Israel CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. GCC Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 56. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 57. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 58. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 59. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 60. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 61. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 62. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 63. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 64. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 65. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 66. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 67. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 68. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 69. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 70. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 71. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies